InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval ...
Nektar Therapeutics may have a pipeline-in-a-drug with rezpegaldesleukin, has additional readouts ahead, and cash until 2027.
A new study from North Carolina State University found that neutrophils—white blood cells that are a key part of the immune ...
The future of dermatology is no longer just skin deep. This year’s American Academy of Dermatology (AAD) annual meeting was held March 7-11, 2025, in Orlando, FL, and it showcased the specialty’s ...
Morning Overview on MSN
The hidden pain-itch link may prove it’s not all in your head
For people living with relentless itching, the suggestion that their symptoms are “all in their head” can feel like a second ...
While Eczema and Dermatitis are skin conditions, they are non-contagious but are often triggered by irritants, allergens, dry ...
A German multicentre study reveals strong patient demand for systemic therapy in atopic dermatitis and psoriasis. Learn more about treatment preferences and drivers.
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback